Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, Hubei, China. This study sought to elucidate a novel predictor of disease severity in patients with coronavirus disease-19 (COVID-19) cased by SARS-CoV-2.
Methods Patients enrolled in this study were all hospitalized with COVID-19 in the Central Hospital of Wuhan, China. Clinical features, chronic comorbidities, demographic data, and laboratory and radiological data were reviewed. The outcomes of patients with severe pneumonia and those with non-severe pneumonia were compared using the Statistical Package for the Social Sciences (IBM Corp., Armonk, NY, USA) to explore clinical characteristics and risk factors. The receiver operating characteristic curve was used to screen optimal predictors from the risk factors and the predictive power was verified by internal validation.
Results A total of 377 patients diagnosed with COVID-19 were enrolled in this study, including 117 with severe pneumonia and 260 with non-severe pneumonia. The independent risk factors for severe pneumonia were age [odds ratio (OR): 1.059, 95% confidence interval (CI): 1.036–1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180–1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129–1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013–1.107; p = 0.011). We identified a product of N/L*CRP*D-dimer as having an important predictive value for the severity of COVID-19. The cutoff value was 5.32. The negative predictive value of less than 5.32 for the N/L*CRP*D-dimer was 93.75%, while the positive predictive value was 46.03% in the test sets. The sensitivity and specificity were 89.47% and 67.42%. In the training sets, the negative and positive predictive values were 93.80% and 41.32%, respectively, with a specificity of 70.76% and a sensitivity of 89.87%.
Conclusions A product of N/L*CRP*D-dimer may be an important predictor of disease severity in patients with COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors have had no support to declare related to the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Support: The authors have had no support to declare related to the manuscript.
Disclosure Statement: All other authors report no conflicts of interest.
Data Availability
All data during the study are available in a repository or online.
Abbreviation List
- ALB
- serum albumin
- ALT
- alanine transaminase
- ARDS
- acute respiratory distress syndrome
- AST
- aspartate aminotransferase
- AUC
- area under the receiver operating characteristic curve
- BUN
- blood urea nitrogen
- COVID-19
- coronavirus disease-19
- Cr
- serum creatinine
- CHD
- coronary heart disease
- CRP
- C-reactive protein
- CT
- computed tomography
- HBP
- high blood pressure
- L
- lymphocyte
- N
- neutrophil
- N/L
- ratio of neutrophils to lymphocytes
- N/L*CRP*D-dimer
- product of N/L, CRP, and D-dimer
- ROC
- receiver operating characteristic
- SARS
- severe acute respiratory syndrome
- SARS-CoV-2
- severe acute respiratory syndrome (SARS) coronavirus 2
- T2DM
- type 2 diabetes mellitus
- WBC
- white blood cell
